334 related articles for article (PubMed ID: 28373298)
1. MOB1 Mediated Phospho-recognition in the Core Mammalian Hippo Pathway.
Couzens AL; Xiong S; Knight JDR; Mao DY; Guettler S; Picaud S; Kurinov I; Filippakopoulos P; Sicheri F; Gingras AC
Mol Cell Proteomics; 2017 Jun; 16(6):1098-1110. PubMed ID: 28373298
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Protein Interactions by
Xiong S; Couzens AL; Kean MJ; Mao DY; Guettler S; Kurinov I; Gingras AC; Sicheri F
Mol Cell Proteomics; 2017 Jun; 16(6):1111-1125. PubMed ID: 28373297
[TBL] [Abstract][Full Text] [Related]
3. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling.
Mana-Capelli S; McCollum D
J Biol Chem; 2018 Nov; 293(47):18230-18241. PubMed ID: 30266805
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for Mob1-dependent activation of the core Mst-Lats kinase cascade in Hippo signaling.
Ni L; Zheng Y; Hara M; Pan D; Luo X
Genes Dev; 2015 Jul; 29(13):1416-31. PubMed ID: 26108669
[TBL] [Abstract][Full Text] [Related]
5. The characterisation of LATS2 kinase regulation in Hippo-YAP signalling.
Hoa L; Kulaberoglu Y; Gundogdu R; Cook D; Mavis M; Gomez M; Gomez V; Hergovich A
Cell Signal; 2016 May; 28(5):488-497. PubMed ID: 26898830
[TBL] [Abstract][Full Text] [Related]
6. The MST4-MOB4 complex disrupts the MST1-MOB1 complex in the Hippo-YAP pathway and plays a pro-oncogenic role in pancreatic cancer.
Chen M; Zhang H; Shi Z; Li Y; Zhang X; Gao Z; Zhou L; Ma J; Xu Q; Guan J; Cheng Y; Jiao S; Zhou Z
J Biol Chem; 2018 Sep; 293(37):14455-14469. PubMed ID: 30072378
[TBL] [Abstract][Full Text] [Related]
7. Protein kinases of the Hippo pathway: regulation and substrates.
Avruch J; Zhou D; Fitamant J; Bardeesy N; Mou F; Barrufet LR
Semin Cell Dev Biol; 2012 Sep; 23(7):770-84. PubMed ID: 22898666
[TBL] [Abstract][Full Text] [Related]
8. Stable MOB1 interaction with Hippo/MST is not essential for development and tissue growth control.
Kulaberoglu Y; Lin K; Holder M; Gai Z; Gomez M; Assefa Shifa B; Mavis M; Hoa L; Sharif AAD; Lujan C; Smith ESJ; Bjedov I; Tapon N; Wu G; Hergovich A
Nat Commun; 2017 Sep; 8(1):695. PubMed ID: 28947795
[TBL] [Abstract][Full Text] [Related]
9. Structural and Biochemical Analyses of the Core Components of the Hippo Pathway.
Ni L; Luo X
Methods Mol Biol; 2019; 1893():239-256. PubMed ID: 30565138
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.
Chen M; Wang M; Xu S; Guo X; Jiang J
Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204
[TBL] [Abstract][Full Text] [Related]
11. Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.
Couzens AL; Knight JD; Kean MJ; Teo G; Weiss A; Dunham WH; Lin ZY; Bagshaw RD; Sicheri F; Pawson T; Wrana JL; Choi H; Gingras AC
Sci Signal; 2013 Nov; 6(302):rs15. PubMed ID: 24255178
[TBL] [Abstract][Full Text] [Related]
12. WWC proteins mediate LATS1/2 activation by Hippo kinases and imply a tumor suppression strategy.
Qi S; Zhu Y; Liu X; Li P; Wang Y; Zeng Y; Yu A; Wang Y; Sha Z; Zhong Z; Zhu R; Yuan H; Ye D; Huang S; Ling C; Xu Y; Zhou D; Zhang L; Yu FX
Mol Cell; 2022 May; 82(10):1850-1864.e7. PubMed ID: 35429439
[TBL] [Abstract][Full Text] [Related]
13. Arsenic-induced cutaneous hyperplastic lesions are associated with the dysregulation of Yap, a Hippo signaling-related protein.
Li C; Srivastava RK; Elmets CA; Afaq F; Athar M
Biochem Biophys Res Commun; 2013 Sep; 438(4):607-12. PubMed ID: 23942117
[TBL] [Abstract][Full Text] [Related]
14. MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway.
Meng Z; Moroishi T; Mottier-Pavie V; Plouffe SW; Hansen CG; Hong AW; Park HW; Mo JS; Lu W; Lu S; Flores F; Yu FX; Halder G; Guan KL
Nat Commun; 2015 Oct; 6():8357. PubMed ID: 26437443
[TBL] [Abstract][Full Text] [Related]
15.
Kim E; Kang JG; Kang MJ; Park JH; Kim YJ; Kweon TH; Lee HW; Jho EH; Lee YH; Kim SI; Yi EC; Park HW; Yang WH; Cho JW
Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14259-14269. PubMed ID: 32513743
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for autoinhibition and its relief of MOB1 in the Hippo pathway.
Kim SY; Tachioka Y; Mori T; Hakoshima T
Sci Rep; 2016 Jun; 6():28488. PubMed ID: 27335147
[TBL] [Abstract][Full Text] [Related]
17. Sphingosylphosphorylcholine regulates the Hippo signaling pathway in a dual manner.
Kemppainen K; Wentus N; Lassila T; Laiho A; Törnquist K
Cell Signal; 2016 Dec; 28(12):1894-1903. PubMed ID: 27634386
[TBL] [Abstract][Full Text] [Related]
18. Hippo and PI5P4K signaling intersect to control the transcriptional activation of YAP.
Palamiuc L; Johnson JL; Haratipour Z; Loughran RM; Choi WJ; Arora GK; Tieu V; Ly K; Llorente A; Crabtree S; Wong JCY; Ravi A; Wiederhold T; Murad R; Blind RD; Emerling BM
Sci Signal; 2024 May; 17(838):eado6266. PubMed ID: 38805583
[TBL] [Abstract][Full Text] [Related]
19. Molecular chaperone Hsp27 regulates the Hippo tumor suppressor pathway in cancer.
Vahid S; Thaper D; Gibson KF; Bishop JL; Zoubeidi A
Sci Rep; 2016 Aug; 6():31842. PubMed ID: 27555231
[TBL] [Abstract][Full Text] [Related]
20. Hippo Signaling in Mitosis: An Updated View in Light of the MEN Pathway.
Hergovich A
Methods Mol Biol; 2017; 1505():265-277. PubMed ID: 27826870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
